Pharmaceutical Industry

The State of the External Attack Surface

Discover the most common vulnerabilities and top risk exposures

Pharmaceutical Industry

The State of the External Attack Surface

Discover the most common vulnerabilities and top risk exposures

Share:

Share on linkedin
Share on facebook
Share on twitter

What’s inside?

This report examines the security posture of the pharmaceutical industry while delivering unique insights into external attack surface exposures and security issues that pharmaceutical companies are currently experiencing.

Read this to learn about:

  1. Most commonly exposed services in pharmceutical comanies’ external attack surface
  2. The most prevalent critical security issues discovered
  3. How to reduce unknown exposures and IT security risks

The data in this report was derived from Reposify’s External Attack Surface Management platform during March 2021. The report presents information about exposure of services and cybersecurity risks, which are prevalent among leading pharmaceutical companies and their 600+ subsidiaries worldwide.

Read Next

Implement these 31 security tips for reducing attack surface risks and unknown exposures.
The financial industry's IT ecosystem is more distributed than ever before. With a growing number of breaches and security incidents resulting from unknown internet exposures, financial industry security leaders are now looking to gain better visibility of their organizations' external attack surfaces.
Mapping your complete external attack surface is critical but no easy task. Read this guide to learn about the risks resulting from unknown assets and discover the new way to safeguard your perimeter-less network.